Intracameral thrombin and the corneal endothelium.
We perfused the endothelia of isolated human corneas mounted in the specular microscope with BSS Plus containing 1,000-U/ml or 100-U/ml dilutions of two commercially available topical thrombin preparations. Corneas perfused with thrombin at 1,000 U/ml showed intracellular and intercellular vacuole formation and altered junctional complexes. As listed on the package inserts, the thrombin preparations contained preservatives and other additives that present a significant osmotic load in 1,000-U/ml preparations. Corneas perfused with 100-U/ml thrombin solutions showed a significant attenuation in their deswelling rate but no ultrastructural alterations. One available thrombin preparation when diluted to 100 U/ml had a glycine concentration associated with previous retinal electroretinography changes. Polyacrylamide gel electrophoresis of one manufacturer's thrombin solution showed multiple high and low molecular weight constituents. Analysis of particulate contamination showed one 100-U/ml thrombin preparation to have a large quantity of particulates. Although thrombin may be useful when applied topically as an aid in surgical hemostasis, its use intraocularly presents substantial concern regarding the preparation's purity, additives, contaminants, and adverse effects on ocular tissues.
McDermott
M L
ML
Department of Physiology, Medical College of Wisconsin, Milwaukee.
Edelhauser
H F
HF
Mannis
M J
MJ
D000368:Aged; D003315:Cornea / Q000648:ultrastructure; D004340:Drug Contamination; D004591:Electrophoresis, Polyacrylamide Gel; D004728:Endothelium, Corneal / Q000187:drug effects* / Q000648:ultrastructure; D006801:Humans; D010477:Perfusion; D011506:Proteins / Q000032:analysis; D013917:Thrombin / Q000008:administration & dosage / Q000032:analysis / Q000494:pharmacology*; D013997:Time Factors; D014617:Vacuoles / Q000648:ultrastructure
D011506:Proteins; D013917:Thrombin